Publications

Publications 2017

December 31, 2017
  1. Boyd MA, Amin J, Mallon PW, Kumarasamy N, Lombaard J, Wood R, Chetchotisakd P, Phanuphak P, Mohapi L, Azwa I, Belloso WH, Molina JM, Hoy J, Moore CL, Emery S, Cooper DA; SECOND-LINE Study Group. Body composition and metabolic outcomes after 96 weeks of treatment with ritonavir-boosted lopinavir plus either nucleoside or nucleotide reverse transcriptase inhibitors or raltegravir in patients with HIV with virological failure of a standard first-line antiretroviral therapy regimen: a substudy of the randomised, open-label, non-inferiority SECOND-LINE study. Lancet HIV. 2017 Jan;4(1):e13-e20. doi: 10.1016/S2352-3018(16)30189-8. Epub 2016 Nov 1.
  2. Kancheva Landolt N, Bunupuradah T, Achalapong J, Kosalaraksa P, Petdachai W, Ngampiyaskul C, Ubolyam S, Thammajaruk N, Kerr S, Ananworanich J. Carbohydrate, lipid, bone and inflammatory markers in HIV-positive adolescents on antiretroviral therapy and hormonal contraception. J Virus Erad. 2017 Jan 1;3(1):56-60.
  3. Anand T, Nitpolprasert C, Kerr SJ, Apornpong T, Ananworanich J, Phanuphak P, Phanuphak N. Implementation of an online HIV prevention and treatment cascade in Thai men who have sex with men and transgender women using Adam’s Love Electronic Health Record system. J Virus Erad. 2017 Jan 1;3(1):15-23.
  4. Bijker R, Jiamsakul A, Kityo C, Kiertiburanakul S, Siwale M, Phanuphak P, Akanmu S, Chaiwarith R, Wit FW, Sim BL, Boender TS, Ditangco R, Rinke De Wit TF, Sohn AH, Hamers RL. Adherence to antiretroviral therapy for HIV in sub-Saharan Africa and Asia: a comparative analysis of two regional cohorts. J Int AIDS Soc. 2017 Mar 3;20(1):21218. doi: 10.7448/IAS.20.1.21218.
  5. Anand T, Nitpolprasert C, Trachunthong D, Kerr SJ, Janyam S, Linjongrat D, Hightop-Weidman, LB, Phanuphak, P, Ananworanich, J & Phanuphak, N. A novel Online-to-Offline (O2O) model for pre-exposure prophylaxis and HIV testing scale up. J Int AIDS Soc. 2017 Mar 13;20(1):21326. doi: 10.7448/IAS.20.1.21326.
  6. Durier N, Yunihastuti E, Ruxrungtham K, Kinh NV, Kamarulzaman A, Boettiger D, Widhani A, Avihingsanon A, Huy BV, Syed Omar SF, Sanityoso A, Chittmittrapap S, Dung NT, Pillai V, Suwan-Ampai T, Law M, Sohn AH, Matthews G. Chronic hepatitis C infection and liver disease in HIV-coinfected patients in Asia. J Viral Hepat. 2017 Mar;24(3):187-196. doi: 10.1111/jvh.12630. Epub 2016 Dec 5.
  7. Prasithsirikul W, Chongthawonsatid S, Ohata PJ, Keadpudsa S, Klinbuayaem V, Rerksirikul P, Kerr SJ, Ruxrungtham K, Ananworanich J, Avihingsanon A; PROGRESS study team. Depression and anxiety were low amongst virally suppressed, long-term treated HIV-infected individuals enrolled in a public sector antiretroviral program in Thailand. AIDS Care. 2017 Mar;29(3):299-305. doi: 10.1080/09540121.2016.1201194. Epub 2016 Aug 10.
  8. Jamal Mohamed T, Teeraananchai S,  Kerr SJ, Phongsamart W, Nik Yusoff  NK, Hansudewechakul R, Ly PS, Nguyen LV, Sudjaritruk T, Lumbiganon P, Do VC, Kurniati N, Kumarasamy N, Wati DK, Fong MS, Nallusamy R, Kariminia A, Sohn A. Impact of viral load use on treatment switch in perinatally HIV-infected children in Asia. AIDS Res Hum Retroviruses. 2017 Mar;33(3):230-233. doi: 10.1089/AID.2016.0039. Epub 2016 Oct 31.
  9. Prévost J, Zoubchenok D, Richard J, Veillette M, Pacheco B, Coutu M, Brassard N, Parsons MS, Ruxrungtham K, Bunupuradah T, Tovanabutra S, Hwang KK, Moody MA, Haynes BF, Bonsignori M, Sodroski J, Kaufmann DE, Shaw GM, Chenine AL, Finzi A. Influence of the Envelope gp120 Phe 43 Cavity on HIV-1 Sensitivity to Antibody-Dependent Cell-Mediated Cytotoxicity Responses. J Virol. 2017 Mar 13;91(7). pii: e02452-16. doi: 10.1128/JVI.02452-16. Print 2017 Apr 1.
  10. Punyawudho B, Thammajaruk N, Ruxrungtham K, Avihingsanon A. Population pharmacokinetics and dose optimisation of ritonavir-boosted atazanavir in Thai HIV-infected patients. Int J Antimicrob Agents. 2017 Mar;49(3):327-332. doi: 10.1016/j.ijantimicag.2016.11.019. Epub 2017 Jan 18.
  11. Sudjaritruk T, Bunupuradah T, Aurpibul L, Kosalaraksa P, Kurniati N, Prasitsuebsai W, Sophonphan J, Sohn AH, Ananworanich J, Puthanakit T; Bone-D Study Group. Adverse bone health and abnormal bone turnover among perinatally HIV-infected Asian adolescents with virological suppression. HIV Med. 2017 Apr;18(4):235-244. doi: 10.1111/hiv.12418. Epub 2016 Aug 1.
  12. Teerananchai S, Kerr SJ, Amin J, Ruxrungtham K, Law MG. Life expectancy of HIV-positive people after starting combination antiretroviral therapy: a meta-analysis. HIV Med. 2017 Apr;18(4):256-266. doi: 10.1111/hiv.12421. Epub 2016 Aug 31.
  13. Siefried, K. J, Mao, L, Kerr, S, Cysique, L. A, Gates, T. M, McAllister, J, Maynard, A, de Wit, J, Carr, A & The Paart study investigators. Socioeconomic factors explain suboptimal adherence to antiretroviral therapy among HIV-infected Australian adults with viral suppression. PLoS One. 2017 Apr 3;12(4):e0174613. doi: 10.1371/journal.pone.0174613. eCollection 2017.
  14. Kiertiburanakul S, Boettiger D, Ng OT, Van Kinh N, Merati TP, Avihingsanon A, Wong WW, Lee MP, Chaiwarith R, Kamarulzaman A, Kantipong P, Zhang F, Choi JY, Kumarasamy N, Ditangco R, Cuong DD, Oka S, Sim BLH, Ratanasuwan W, Ly PS, Yunihastuti E, Pujari S, Ross JL, Law M, Sungkanuparph S; TREAT Asia HIV Observational Databases (TAHOD). Factors associated with pre-treatment HIV RNA: application for the use of abacavir and rilpivirine as the first-line regimen for HIV-infected patients in resource-limited settings. AIDS Res Ther. 2017 May 5;14:27. doi: 10.1186/s12981-017-0151-1. eCollection 2017.
  15. Kawkitinarong K, Suwanpimolkul G, Kateruttanakul P, Manosuthi W, Ubolyam S, Sophonphan J, Avihingsanon A, Ruxrungtham K. Real-Life Clinical Practice of Using the Xpert MTB/RIF Assay in Thailand. Clin Infect Dis. 2017 May 15;64(suppl_2):S171-S178. doi: 10.1093/cid/cix151.
  16. Teeraananchai, S; Bunupuradah, T; Puthanakit, T; Kerr, SJ; Ruxrungtham, K; Chaivooth, S; Bhakeecheep, S; Law, MG & Chokephaibulkit, K. First line antiretroviral treatment outcomes and durability in HIV-infected children treated through the universal coverage health program in Thailand. J Acquir Immune Defic Syndr. 2017 Jun 1;75(2):219-225. doi: 10.1097/QAI.0000000000001351.
  17. Pankam T, Kerr, SJ, Teeratakulpisan, N, Rodbamrung, P, Wongkanya R, Keelawat S, Ruangritchankul K, Hongchookiat P, Watanapokasin, R, Phanuphak, N. Human papillomavirus in anal biopsy tissues and liquid-based cytology samples of HIV-positive and HIV-negative Thai men who have sex with men. Papillomavirus Res. 2017 Jun;3:149-154. doi: 10.1016/j.pvr.2017.04.006. Epub 2017 May 5.
  18. Suwanpimolkul G, Kawkitinarong K, Manosuthi W, Sophonphan J, Gatechompol S, Ohata PJ, Ubolyam S, Iampornsin T, Katerattanakul P, Avihingsanon A, Ruxrungtham K. Utility of urine lipoarabinomannan (LAM) in diagnosing tuberculosis and predicting mortality with and without HIV: prospective TB cohort from the Thailand Big City TB Research Network. Int J Infect Dis. 2017 Jun;59:96-102. doi: 10.1016/j.ijid.2017.04.017. Epub 2017 Apr 27.
  19. Anand, T; Nitpolprasert, C; Kerr, SJ; Muessig, KE; Promthong, S; Chomchey, N; Hightow-Weidman, LB; Chaiyahong, P; Phanuphak, P; Ananworanich, J & Phanuphak, N. A qualitative study of Thai HIV-positive young men who have sex with men and transgender women demonstrates the need for eHealth interventions to optimize the HIV care continuum. AIDS Care. 2017 Jul;29(7):870-875. doi: 10.1080/09540121.2017.1286288. Epub 2017 Feb 3.
  20. Sudjaritruk T, Aurpibul L, Ly PS, Le TP, Bunupuradah T, Hansudewechakul R, Lumbiganon P, Chokephaibulkit K, Nik Yusoff NK, Nguyen LV, Mohd Razali KA, Fong MS, Nallusamy RA, Kurniati N, Do VC, Boettiger DC, Sohn AH, Kariminia A. Incidence of Postsuppression Virologic Rebound in Perinatally HIV-Infected Asian Adolescents on Stable Combination Antiretroviral Therapy. J Adolesc Health. 2017 Jul;61(1):91-98. doi: 10.1016/j.jadohealth.2017.01.014. Epub 2017 Mar 24.
  21. Putcharoen O, Wattanachanya L, Sophonphan J, Siwamogsatham S, Sapsirisavat V, Gatechompol S, Phonphithak, S, Kerr SJ, Avihingsanon Y, Ruxrungtham K, Avihingsanon A & the HIV-NAT study team. New-Onset Diabetes in HIV Treated Adults from Thailand: Predictors, long-term renal and cardiovascular outcomes. AIDS. 2017 Jul 17;31(11):1535-1543. doi: 10.1097/QAD.0000000000001496.
  22. Landolt NK, Achalapong J, Kosalaraksa P, Petdachai W, Ngampiyaskul C, Kerr S, Boonyanurak P, Ananworanich J & Bunupuradah T. Strategies to improve the uptake of effective contraception in perinatally HIV-infected adolescents. J Virus Erad. 2017 Jul 1;3(3):152-156.
  23. Avihingsanon A, Maek-a-nantawat W, Gatechompol S, Sapsirisavat V, Thiansanguankul W, Sophonphan J, Thammajaruk N, Ubolyam S, Burger DM, Ruxrungtham K. 144 week Efficacy and Safety of a once daily single tablet regimen of tenofovir, lamivudine and efavirenz among ARV naïve and ARV experienced HIV-1 infected Thai adults.
    Int J Infect Dis. 2017 Aug;61:89-96. doi: 10.1016/j.ijid.2017.06.009. Epub 2017 Jun 13.
  24. Teeraananchai S, Kerr SJ, Puthanakit T, Bunupuradah T, Ruxrungtham K, Chaivooth S, Law MG, Chokephaibulkit, K. Attrition of children receiving antiretroviral treatment through the Universal Coverage Health Program in Thailand. J Pediatr. 2017 Sep;188:210-216.e1. doi: 10.1016/j.jpeds.2017.05.035. Epub 2017 Jun 9.
  25. Hoy JF, Grund B, Roediger M, Schwartz AV, Shepherd J, Avihingsanon A, Badal-Faesen S, de Wit S, Jacoby S, Rosa AL, Pujari S, Schechter M, White D, Ensrud K, Aagaard PD, Carr A, for the INSIGHT START Bone Mineral Density substudy group. Immediate Initiation of Antiretroviral Therapy for HIV infection Accelerates Bone Loss relative to Deferring Therapy: Findings from the START Bone Mineral Density substudy, a randomized trial. J Bone Miner Res. 2017 Sep;32(9):1945-1955. doi: 10.1002/jbmr.3183. Epub 2017 Jun 26.
  26. Dwyer DE, Lynfield R, Losso MH, Davey RT, Cozzi-Lepri A, Wentworth D, Uyeki TM, Gordin F, Angus B, Qvist T, Emery S, Lundgren J, Neaton JD; INSIGHT Influenza Study Group. Comparison of the Outcomes of Individuals With Medically Attended Influenza A and B Virus Infections Enrolled in 2 International Cohort Studies Over a 6-Year Period: 2009-2015. Open Forum Infect Dis. 2017 Oct 7;4(4):ofx212. doi: 10.1093/ofid/ofx212. eCollection 2017 Fall.
  27. Pett SL, Kunisaki KM, Wentworth D, Griffin TJ, Kalomenidis I, Nahra R, Montejano Sanchez R, Hodgson SW, Ruxrungtham K, Dwyer D, Davey RT, Wendt CH; INSIGHT FLU003 Plus Study Group. Increased Indoleamine-2,3-Dioxygenase Activity Is Associated With Poor Clinical Outcome in Adults Hospitalized With Influenza in the INSIGHT FLU003Plus Study. Open Forum Infect Dis. 2017 Oct 25;5(1):ofx228. doi: 10.1093/ofid/ofx228. eCollection 2018 Jan.
  28. Landolt NK, Do T, Kasipong N, Kriengsinyot R, Ubolyam S, Mahanontharit A, Pankam T, Apornpong T, Avihingsanon A, Ananworanich J, Phanuphak N, Chaithongwongwatthana S. Low-level genital HIV shedding in Thai HIV-infected women with suppressed plasma viral load after menopause: a longitudinal study. J Virus Erad. 2017 Oct 1;3(4):204-207.
  29. Chaivooth S, Bhakeecheep S, Ruxrungtham K, Teeraananchai S, Kerr SJ, Teeraratkul A, Sirinirund P, Ongwandee S, Avihingsanon A, Benjarattanaporn P, Phanuphak N, Sungkanuparph S, Mekthon S, Phanuphak P. The challenges of ending AIDS in Asia: outcomes of the Thai National AIDS Universal Coverage Programme, 2000-2014. J Virus Erad. 2017 Oct 1;3(4):192-199.
  30. Prasitsuebsai W, Sophonphan J, Chokephaibulkit K, Wongsawat J, Kanjanavanit S, Kosalaraksa P, Ngampiyakul C, Sangkla P, Hansudewechakul R, Kerr SJ, Puthanakit T, Ananworanich J on behalf of the HIV-NAT 113 study group. Treatment outcomes of third-line antiretroviral regimens in HIV-infected Thai children. Pediatr Infect Dis J. 2017 Oct;36(10):967-972. doi: 10.1097/INF.0000000000001638.
  31. Rungtivasuwan K, Avihingsanon A, Thammajaruk N, Mitruk S, Burger DM, Ruxrungtham K, Sukasem C, Punyawudho B. Pharmacogenetics-based population pharmacokinetic analysis of tenofovir in Thai HIV-infected patients. Pharmacogenomics. Pharmacogenomics. 2017 Nov;18(16):1481-1490. doi: 10.2217/pgs-2017-0128. Epub 2017 Oct 24.
  32. Cahn P, Kaplan R, Sax PE, Squires K, Molina JM, Avihingsanon A, Ratanasuwan W, Rojas E, Rassool M, Bloch M, Vandekerckhove L, Ruane P, Yazdanpanah Y, Katlama C, Xu X, Rodgers A, East L, Wenning L, Rawlins S, Homony B, Sklar P, Nguyen BY, Leavitt R, Teppler H; ONCEMRK Study Group . Raltegravir 1200 mg once daily versus raltegravir 400 mg twice daily, with tenofovir disoproxil fumarate and emtricitabine, for previously untreated HIV-1 infection: a randomised, double-blind, parallel-group, phase 3, non-inferiority trial. Lancet HIV. 2017 Nov;4(11):e486-e494. doi: 10.1016/S2352-3018(17)30128-5. Epub 2017 Sep 11.
  33. Pintye J, Bacchetti P, Teeraananchai S, Kerr S, Prasitsuebsai W, Singtoroj T, Kuncze K, Louie A, Koss CA, Jin C, Phung N, Horng H, Sohn AH, & Gandhi M. Lopinavir Hair Concentrations are the Strongest Predictor of Viremia in HIV-infected Asian Children and Adolescents on Second-line Antiretroviral Therapy. J Acquir Immune Defic Syndr. 2017 Dec 1;76(4):367-371. doi: 10.1097/QAI.0000000000001527.
  34. Beigel JH, Bao Y, Beeler J, Manosuthi W, Slandzicki A, Dar SM, Panuto J, Beasley RL, Perez-Patrigeon S, Suwanpimolkul G, Losso MH, McClure N, Bozzolo DR, Myers C, Holley HP Jr, Hoopes J, Lane HC, Hughes MD, Davey RT; IRC003 Study Team. Oseltamivir, amantadine, and ribavirin combination antiviral therapy versus oseltamivir monotherapy for the treatment of influenza: a multicentre, double-blind, randomised phase 2 trial. Lancet Infect Dis. 2017 Dec;17(12):1255-1265. doi: 10.1016/S1473-3099(17)30476-0. Epub 2017 Sep 22.
  35. Jung IY, Boettiger D, Wong WW, Lee MP, Kiertiburanakul S, Chaiwarith R, Avihingsanon A, Tanuma J, Kumarasamy N, Kamarulzaman A, Zhang F, Kantipong P, Ng OT, Sim BLH, Law M, Ross J, Choi JY. The treatment outcomes of antiretroviral substitutions in routine clinical settings in Asia; data from the TREAT Asia HIV Observational Database (TAHOD). J Int AIDS Soc. 2017 Dec;20(4). doi: 10.1002/jia2.25016.
  36. Sangarlangkarn A, Avihingsanon A, Appelbaum JS. Application of Geriatric Principles and Care Models in HIV and Aging. Interdiscip Top Gerontol Geriatr. 2017;42:119-133. Epub 2016 Nov 22.
  37. Ohata PJ, Nanthapisal K, Ruengpanyathip C, Sattayamong P, Avihingsanon A, Gatechompol S, Bunupurdah T, Hiransuthikul A, Kerr SJ, Do T, Puthanakit T, Kroon E, Colby D, Ramautarsing R, Kraus S, Harrison B, Bakkali T, Putcharoen O, Ruxrungtham K, Phanuphak Pon behalf of the Symposium Team. Decades researches and implementation science of HIV prevention, treatment and cure: Highlights from Symposium 2017. Future Virology. 2017;12(5). doi:10.2217/fvl-2017-0016 (Epub ahead of print)
  38. Sudjaritruk T, Bunupuradah T, Aurpibul L, Kosalaraksa P, Kurniati N, Sophonphan J, Ananworanich J, Puthanakit T; Bone-D study group. Impact of tenofovir disoproxil fumarate on bone metabolism and bone mass among perinatally HIV-infected Asian adolescents. Antivir Ther. 2017;22(6):471-479. doi: 10.3851/IMP3103. Epub 2016 Oct 27.
  39. Teeraananchai, S, Chaivooth, S, Kerr, SJ, Bhakeecheep, S, Avihingsanon, A, Teeraratkul, A, Sirinirund, P, Law, MG & Ruxrungtham, K. Life expectancy after initiation of combination antiretroviral therapy in Thailand. Antivir Ther. 2017;22(5):393-402. doi: 10.3851/IMP3121. Epub 2017 Jan 5.